首頁 > 市場調查報告書 > 醫療設備

運輸/物流生技設備

市場調查報告書

商品編碼

1570913

醫療保健冷鏈物流市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Healthcare Cold Chain Logistics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月08日 | 出版商:

Global Market Insights Inc. | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年，全球醫療保健冷鏈物流市場價值為550億美元，預計2024年至2032年複合年成長率將超過9%。嚴格的溫度管理對於整個供應鏈保持產品功效至關重要，從而導致對冷鏈解決方案的投資增加。醫療保健物流提供者正在擴展到新的地區，增強分銷網路並確保可靠的交付，這支持全球健康計劃並滿足對溫度敏感的醫療保健解決方案不斷成長的需求。

整個醫療保健冷鏈物流行業根據產品、服務、溫度範圍、最終用戶和地區進行分類。

市場依產品分為生物製藥、臨床試驗材料、疫苗等。 2023年，生物製藥佔超過44%的市場。生物製藥的日益突出正在推動先進溫控物流解決方案的採用。複雜的監控系統，例如即時溫度感測器和自動資料記錄，對於保障產品完整性至關重要。增強的追蹤技術確保遵守嚴格的法規並提高供應鏈的可靠性，解決生物製藥分銷的獨特挑戰。

市場依服務分為運輸、儲存、包裝等。 2023年，運輸服務約佔市場佔有率的47%。運輸服務擴大採用電動和混合動力汽車，以減少碳排放並提高溫控物流的永續性。這種向環保運輸選擇的轉變補充了先進的溫度管理系統，確保高效且對環境負責的溫度敏感產品的交付。這種方法符合日益成長的環境法規和對綠色供應鏈實踐的需求。

北美在全球醫療保健冷鏈物流市場中佔據主導地位，到2023年，其主要佔有率約為34%。公司正在採用人工智慧驅動的溫度監控和自動儲存系統等先進技術來提高效率和合規性。對現代化的關注旨在滿足對溫度敏感產品不斷成長的需求，並簡化整個地區的分銷流程。

產業生態系統分析
供應商格局
- 藥品製造商
- 包裝供應商
- 冷鏈物流供應商
- 冷庫供應商
- 技術提供者
- 經銷商
- 最終用戶
利潤率分析
技術與創新格局
專利分析
重要新聞和舉措
監管環境
衝擊力
- 成長動力
  - 對生物製劑和疫苗的需求不斷成長
  - 包裝和監控方面的技術進步
  - 擴大全球藥品供應鏈
  - 臨床試驗和研究活動的成長
- 產業陷阱與挑戰
  - 維護冷鏈基礎設施的成本高昂
  - 複雜的物流和溫控要求
成長潛力分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
生物製藥
疫苗
臨床試驗材料
其他

第 6 章：市場估計與預測：按服務分類，2021 - 2032 年

主要趨勢
運輸
貯存
包裝
其他

第 7 章：市場估計與預測：按溫度範圍分類，2021 - 2032 年

主要趨勢
冷藏（2°C 至 8°C）
冷凍（-20°C 至 -80°C）
受控室溫（15°C 至 25°C）

第 8 章：市場估計與預測：按最終用戶分類，2021 - 2032 年

主要趨勢
生物製藥公司
醫院和診所
研究機構
其他

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 西班牙
- 義大利
- 俄羅斯
- 北歐人
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 東南亞
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
MEA
- 阿拉伯聯合大公國
- 南非
- 沙烏地阿拉伯
- MEA 的其餘部分

第 10 章：公司簡介

American Airlines Cargo
Averitt Express
Cardinal Health
Cavalier Logistics
CEVA Logistics
Cryoport
DB Schenker
DHL International GmbH
DSV
Envirotainer
Expeditors International
FedEx Corporation
Geodis
J.B. Hunt Transport Services
Kuehne + Nagel International AG
Sinotrans Limited
Toll Group
United Parcel Service, Inc.
World Courier (a part of AmerisourceBergen)
XPO Logistics

簡介目錄

Product Code: 10718

The Global Healthcare Cold Chain Logistics Market was valued at USD 55 billion in 2023 and is projected to grow at a CAGR of over 9% from 2024 to 2032. The global demand for biologics and vaccines drives the need for advanced temperature-controlled logistics. Stringent temperature management is crucial throughout the supply chain to maintain product efficacy, leading to increased investments in cold chain solutions. Healthcare logistics providers are expanding into new regions, enhancing distribution networks, and ensuring reliable deliveries, which supports global health initiatives and meets the rising demand for temperature-sensitive healthcare solutions.

The overall healthcare cold chain logistics industry is classified based on the product, service, temperature range, end-user, and region.

The market is segmented by product into biopharmaceuticals, clinical trial materials, vaccines, and others. In 2023, biopharmaceuticals held over 44% of the market share. The growing prominence of biopharmaceuticals is driving the adoption of advanced temperature-controlled logistics solutions. Sophisticated monitoring systems, such as real-time temperature sensors and automated data logging, are essential to safeguard product integrity. Enhanced tracking technologies ensure compliance with stringent regulations and improve supply chain reliability, addressing the unique challenges of biopharmaceutical distribution.

The market is categorized by service into transportation, storage, packaging, and others. In 2023, transportation services accounted for around 47% of the market share. Transportation services are increasingly incorporating electric and hybrid vehicles to reduce carbon emissions and improve sustainability in temperature-controlled logistics. This shift towards eco-friendly transportation options complements advanced temperature management systems, ensuring efficient and environmentally responsible delivery of temperature-sensitive products. This approach aligns with growing environmental regulations and the demand for greener supply chain practices.

North America dominated the global healthcare cold chain logistics market, with a major share of around 34% in 2023. In North America, there is a significant push towards enhancing cold chain infrastructure through digitalization and automation. Companies are adopting advanced technologies such as AI-driven temperature monitoring and automated storage systems to improve efficiency and compliance. This focus on modernization aims to address the rising demand for temperature-sensitive products and streamline the distribution process across the region.

Chapter 1 Methodology and Scope

1.1 Research design
- 1.1.1 Research approach
- 1.1.2 Data collection methods
1.2 Base estimates and calculations
- 1.2.1 Base year calculation
- 1.2.2 Key trends for market estimates
1.3 Forecast model
1.4 Primary research and validation
- 1.4.1 Primary sources
- 1.4.2 Data mining sources
1.5 Market definitions

Chapter 2 Executive Summary

2.1 Industry 360° synopsis, 2021 - 2032

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Supplier landscape
- 3.2.1 Pharmaceuticals manufacturers
- 3.2.2 Packaging suppliers
- 3.2.3 Cold chain logistics providers
- 3.2.4 Cold storage providers
- 3.2.5 Technology providers
- 3.2.6 Distributors
- 3.2.7 End Users
3.3 Profit margin analysis
3.4 Technology and innovation landscape
3.5 Patent analysis
3.6 Key news and initiatives
3.7 Regulatory landscape
3.8 Impact forces
- 3.8.1 Growth drivers
  - 3.8.1.1 Rising demand for biologics and vaccines
  - 3.8.1.2 Technological advancements in packaging and monitoring
  - 3.8.1.3 Expansion of global pharmaceutical supply chains
  - 3.8.1.4 Growth in clinical trials and research activities
- 3.8.2 Industry pitfalls and challenges
  - 3.8.2.1 High costs of maintaining cold chain infrastructure
  - 3.8.2.2 Complex logistics and temperature control requirements
3.9 Growth potential analysis
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($Bn, 000' tons)

5.1 Key trends
5.2 Biopharmaceuticals
5.3 Vaccines
5.4 Clinical trial materials
5.5 Others

Chapter 6 Market Estimates and Forecast, By Service, 2021 - 2032 ($Bn)

6.1 Key trends
6.2 Transportation
6.3 Storage
6.4 Packaging
6.5 Others

Chapter 7 Market Estimates and Forecast, By Temperature Range, 2021 - 2032 ($Bn)

7.1 Key trends
7.2 Refrigerated (2°C to 8°C)
7.3 Frozen (-20°C to -80°C)
7.4 Controlled room temperature (15°C to 25°C)

Chapter 8 Market Estimates and Forecast, By End User, 2021 - 2032 ($Bn, 000' tons)

8.1 Key trends
8.2 Biopharmaceutical companies
8.3 Hospitals and clinics
8.4 Research Institutions
8.5 Others

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($Bn, 000' tons)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 UK
- 9.3.2 Germany
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Russia
- 9.3.7 Nordics
- 9.3.8 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 South Korea
- 9.4.5 Australia
- 9.4.6 Southeast Asia
- 9.4.7 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 MEA
- 9.6.1 UAE
- 9.6.2 South Africa
- 9.6.3 Saudi Arabia
- 9.6.4 Rest of MEA